> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 20 NDAs Not Withdrawn Due to Safety/Efficacy: FDA
- URL: https://www.fdaweb.com/20-ndas-not-withdrawn-due-to-safety-efficacy-fda/
- Published: 2021-03-24T12:00:00.000Z
- Updated: 2026-09-14T16:52:09.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148949

*Federal Register* notice: FDA has determined that 20 drug products were not withdrawn from sale for safety or effectiveness reasons. The determination means that the agency will not begin procedures to withdraw ANDAs that refer the drug products, and it will continue to approve ANDAs that refer to the products as long as they meet relevant legal and regulatory requirements. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2021-03-24/pdf/2021-06059.pdf?ref=fdaweb.com).